Gait Speed

Gait speed, the pace at which someone walks over a short measured distance at their usual comfortable pace, is one of the simplest physical measurements available and has repeatedly proven to be a strong, independent predictor of survival in older adults. The claim: walking speed alone, without any other clinical information, predicts remaining life expectancy about as well as combinations of chronic disease counts, smoking history, blood pressure, and BMI.

A pooled analysis of 9 cohort studies combining individual data from 34,485 community-dwelling adults aged 65 and older, followed for 6 to 21 years with 17,528 deaths recorded, found gait speed was associated with survival in every included study, with a pooled hazard ratio of 0.88 (95% CI 0.87-0.90, p<0.001) for each 0.1 m/s increase in walking speed [1]. At age 75, predicted 10-year survival ranged from just 19% to 87% in men and 35% to 91% in women across the observed range of gait speeds, and prediction models based only on age, sex, and gait speed performed comparably to models using age, sex, chronic disease count, smoking history, blood pressure, BMI, and hospitalization history [1]. A gait speed around 0.8 m/s corresponded to the median expected life expectancy for a person's age and sex, while speeds of 1.2 m/s or faster predicted exceptionally long survival [1]. A broader 2018 systematic review and meta-analysis spanning 48 independent cohorts and 101,945 participants confirmed the relationship, finding each 0.1 m/s reduction in gait speed was associated with a 12% increased risk of earlier mortality (hazard ratio 1.12, 95% CI 1.09-1.14) and an 8% increased risk of cardiovascular disease (HR 1.08, 95% CI 1.03-1.13), though no association was found with cancer risk [2].

How to measure it: timed walk over a fixed short distance, commonly 4 or 6 meters, at usual comfortable walking pace from a standing start, with speed calculated as distance divided by time in meters per second [4]. It requires no special equipment beyond a stopwatch and a marked walkway, making it one of the least expensive functional assessments in clinical use, a point echoed in clinical commentary on gait speed as a vital-sign-like predictor [6].

How to intervene on it: structured exercise programs combining resistance training and aerobic activity reliably improve gait speed in randomized trials of older adults, particularly programs targeting lower-body strength and balance. Not just baseline speed but its trajectory matters: a study of 2,364 well-functioning older adults found those with a fast-declining gait speed trajectory (losing 0.030 m/s per year, roughly 2.4% annually) had a 90% greater mortality risk than those with a slow-declining trajectory, suggesting that slowing the rate of decline, not only raising baseline speed, is a meaningful target [3].

Critics point out that gait speed, like grip strength, is likely a downstream marker of accumulated physiological decline, sarcopenia, and disease burden rather than an isolated cause of death [4], and that a related frailty index built partly on functional measures has shown poor individual-level predictive value even though it performs well at a population level [5].

The plain takeaway: a simple timed walk captures information about physiological reserve that rivals detailed clinical risk assessments in predicting survival in older adults, and both the absolute speed and its rate of decline over time carry independent prognostic weight, making gait speed one of the most cost-effective functional biomarkers available.